DC
Therapeutic Areas
Anteris Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DurAVR™ THV System | Severe Aortic Stenosis (Symptomatic) | Early Feasibility Study |
Leadership Team at Anteris Technologies
WP
Wayne Paterson, PhD
Chief Executive Officer & Managing Director
FR
Felix Roosen
Chief Operating Officer
AM
Annie Miller
Chief Financial Officer
JW
John W. Cumming
Non-Executive Chairman
DA
Dr. Andrew Holden, MBChB, FRANZCR, EBIR
Non-Executive Director
MA
Mark A. Meller
Non-Executive Director